Yersinia controls type III effector delivery into host cells by modulating Rho activity.

Yersinia pseudotuberculosis binds to beta1 integrin receptors, and uses the type III secretion proteins YopB and YopD to introduce pores and to translocate Yop effectors directly into host cells. Y. pseudotuberculosis lacking effectors that inhibit Rho GTPases, YopE and YopT, have high pore forming...

Full description

Bibliographic Details
Main Authors: Edison Mejía, James B Bliska, Gloria I Viboud
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-01-01
Series:PLoS Pathogens
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18193942/?tool=EBI
id doaj-dc0ba48c1acb45d4aa958e8905f6017c
record_format Article
spelling doaj-dc0ba48c1acb45d4aa958e8905f6017c2021-04-21T17:20:25ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742008-01-0141e310.1371/journal.ppat.0040003Yersinia controls type III effector delivery into host cells by modulating Rho activity.Edison MejíaJames B BliskaGloria I ViboudYersinia pseudotuberculosis binds to beta1 integrin receptors, and uses the type III secretion proteins YopB and YopD to introduce pores and to translocate Yop effectors directly into host cells. Y. pseudotuberculosis lacking effectors that inhibit Rho GTPases, YopE and YopT, have high pore forming activity. Here, we present evidence that Y. pseudotuberculosis selectively modulates Rho activity to induce cellular changes that control pore formation and effector translocation. Inhibition of actin polymerization decreased pore formation and YopE translocation in HeLa cells infected with Y. pseudotuberculosis. Inactivation of Rho, Rac, and Cdc42 by treatment with Clostridium difficile toxin B inhibited pore formation and YopE translocation in infected HeLa cells. Expression of a dominant negative form of Rac did not reduce the uptake of membrane impermeable dyes in HeLa cells infected with a pore forming strain YopEHJT(-). Similarly, the Rac inhibitor NSC23766 did not decrease pore formation or translocation, although it efficiently hindered Rac-dependent bacterial uptake. In contrast, C. botulinum C3 potently reduced pore formation and translocation, implicating Rho A, B, and/or C in the control of the Yop delivery. An invasin mutant (Y. pseudotuberculosis invD911E) that binds to beta1 integrins, but inefficiently transduces signals through the receptors, was defective for YopE translocation. Interfering with the beta1 integrin signaling pathway, by inhibiting Src kinase activity, negatively affected YopE translocation. Additionally, Y. pseudotuberculosis infection activated Rho by a mechanism that was dependent on YopB and on high affinity bacteria interaction with beta1 integrin receptors. We propose that Rho activation, mediated by signals triggered by the YopB/YopD translocon and from engagement of beta1 integrin receptors, stimulates actin polymerization and activates the translocation process, and that once the Yops are translocated, the action of YopE or YopT terminate delivery of Yops and prevents pore formation.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18193942/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Edison Mejía
James B Bliska
Gloria I Viboud
spellingShingle Edison Mejía
James B Bliska
Gloria I Viboud
Yersinia controls type III effector delivery into host cells by modulating Rho activity.
PLoS Pathogens
author_facet Edison Mejía
James B Bliska
Gloria I Viboud
author_sort Edison Mejía
title Yersinia controls type III effector delivery into host cells by modulating Rho activity.
title_short Yersinia controls type III effector delivery into host cells by modulating Rho activity.
title_full Yersinia controls type III effector delivery into host cells by modulating Rho activity.
title_fullStr Yersinia controls type III effector delivery into host cells by modulating Rho activity.
title_full_unstemmed Yersinia controls type III effector delivery into host cells by modulating Rho activity.
title_sort yersinia controls type iii effector delivery into host cells by modulating rho activity.
publisher Public Library of Science (PLoS)
series PLoS Pathogens
issn 1553-7366
1553-7374
publishDate 2008-01-01
description Yersinia pseudotuberculosis binds to beta1 integrin receptors, and uses the type III secretion proteins YopB and YopD to introduce pores and to translocate Yop effectors directly into host cells. Y. pseudotuberculosis lacking effectors that inhibit Rho GTPases, YopE and YopT, have high pore forming activity. Here, we present evidence that Y. pseudotuberculosis selectively modulates Rho activity to induce cellular changes that control pore formation and effector translocation. Inhibition of actin polymerization decreased pore formation and YopE translocation in HeLa cells infected with Y. pseudotuberculosis. Inactivation of Rho, Rac, and Cdc42 by treatment with Clostridium difficile toxin B inhibited pore formation and YopE translocation in infected HeLa cells. Expression of a dominant negative form of Rac did not reduce the uptake of membrane impermeable dyes in HeLa cells infected with a pore forming strain YopEHJT(-). Similarly, the Rac inhibitor NSC23766 did not decrease pore formation or translocation, although it efficiently hindered Rac-dependent bacterial uptake. In contrast, C. botulinum C3 potently reduced pore formation and translocation, implicating Rho A, B, and/or C in the control of the Yop delivery. An invasin mutant (Y. pseudotuberculosis invD911E) that binds to beta1 integrins, but inefficiently transduces signals through the receptors, was defective for YopE translocation. Interfering with the beta1 integrin signaling pathway, by inhibiting Src kinase activity, negatively affected YopE translocation. Additionally, Y. pseudotuberculosis infection activated Rho by a mechanism that was dependent on YopB and on high affinity bacteria interaction with beta1 integrin receptors. We propose that Rho activation, mediated by signals triggered by the YopB/YopD translocon and from engagement of beta1 integrin receptors, stimulates actin polymerization and activates the translocation process, and that once the Yops are translocated, the action of YopE or YopT terminate delivery of Yops and prevents pore formation.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18193942/?tool=EBI
work_keys_str_mv AT edisonmejia yersiniacontrolstypeiiieffectordeliveryintohostcellsbymodulatingrhoactivity
AT jamesbbliska yersiniacontrolstypeiiieffectordeliveryintohostcellsbymodulatingrhoactivity
AT gloriaiviboud yersiniacontrolstypeiiieffectordeliveryintohostcellsbymodulatingrhoactivity
_version_ 1714666318307786752